| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PCBP3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | MATR3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GUCY1A2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PIGBOS1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | KMT2E | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SLA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SCML2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | EPHB6 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | NCR3LG1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | TAS2R31 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
